Use of parasitic biological agents for prevention and control of autoimmune diseases
AssigneeUniversity of Iowa Research Foundation
InventorsJoel V. Weinstock, David E. Elliott
Life of this patent
Estimating the term…
Loading patent…
AssigneeUniversity of Iowa Research Foundation
InventorsJoel V. Weinstock, David E. Elliott
Estimating the term…
The invention relates to a method of treating an excessive immune response including an aberrant/enhanced Th1 response by administering a helminthic parasite preparation in an amount sufficient to reduce the excessive immune response in an individual. This invention is generally directed to autoimmune diseases which involve an excessive immune response or an aberrant/enhanced Th1 response. More specifically, the present invention is directed to the treatment of Crohn's disease and ulcerative colitis, both known as IBD. While the present invention discloses specific information about the treatment of IBD, the disclosure is in no way limiting. Additionally, rheumatoid arthritis, type 1 diabetes mellitus, lupus erythematosis, sarcoidosis and multiple sclerosis can be treated by the methods and compositions disclosed therein.
A pharmaceutical composition comprising an isolated and purified helminthic parasite preparation, wherein said preparation is prepared from helminths obtained from preparatory animals raised in a specific human pathogen-free environment, and a pharmaceutically acceptable carrier, and wherein said pharmaceutical composition is free of human pathogens.
Dependencies are inferred from the claim text.